Angels for Change is proud to announce a significant milestone in Project PROTECT. Fagron Sterile Services US (FSS), a recipient of the 2023 Project PROTECT grant and a leader 503B outsourcing, has completed the Preparation and Protective phases for preservative-free Dextrose 70% injection solution. The significance of this achievement is highlighted by the recent flooding at Baxter's North Cove manufacturing site due to Hurricane Helene, which prompted the U.S. Food and Drug Administration to include Dextrose on its drug shortage list as of October 12, 2024. The strategic preparations made through Project PROTECT, Dextrose will remain accessible to vulnerable patients, especially PICU and NICU babies, amid anticipated supply chain disruptions.
Angels for Change is proud to announce the continued expansion of Project PROTECT, a pioneering initiative to mitigate drug shortages by building an onshore resilient and redundant supply of vulnerable essential medicines.
“After listening to families and many other organizations at the center of this community, including the Children’s Oncology Group and Angels for Change, we embarked on an aggressive development path to bring a new recombinant erwinia asparaginase option to market, one that will be manufactured under the highest quality standards and provide a reliable supply to meet the needs of our patients.”
We are proud and grateful we could help these Warrior families obtain the life-saving drugs they needed to successfully complete their child’s chemotherapy treatment. Yet we have always maintained our goal is that no parent or patient should ever have to hear, and no doctor should ever have to say, “We don’t have the life-saving drug you need.”
